MktsMarkets

ImmuCell Corporation
NASDAQ: ICCCKey statistics
ICCC News
Stories mentioning ICCC from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 10,357 | 7,626 | 5,506 | 6,445 | 8,067 | 7,750 | 6,012 | 5,473 |
| Cost of Goods Sold | 5,700 | 4,716 | 3,143 | 3,627 | 4,713 | 4,920 | 4,428 | 4,242 |
| Gross Profit | 4,657 | 2,910 | 2,363 | 2,818 | 3,354 | 2,832 | 1,584 | 1,230 |
| Operating Expenses | ||||||||
| Research & Development | 318.00 | 759.00 | 694.00 | 832.00 | 757.00 | 819.00 | 786.00 | 1,031 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 2,688 | 2,969 | 2,343 | 2,248 | 2,236 | 2,211 | 2,158 | 2,617 |
| Operating Income (Loss) | 1,969 | (59.00) | 20.00 | 570.00 | 1,118 | 622.00 | (575.00) | (1,387) |
| Interest Income | 44.00 | 41.00 | 37.00 | 19.00 | ||||
| Interest Expense | 144.00 | 142.00 | ||||||
| Other Expense | (125.00) | (144.00) | ||||||
| Pretax Income | 1,954 | (2,846) | (135.00) | 504.00 | 1,449 | 520.00 | (700.00) | (1,530) |
| Tax Provision | 13.00 | 4.00 | 4.00 | 2.00 | 2.00 | 7.00 | 1.00 | 1.00 |
| Net Income (Loss) | 1,942 | (2,849) | (140.00) | 502.00 | 1,447 | 515.00 | (702.00) | (1,532) |
| Earnings Per Share (Basic) | 0.21 | (0.32) | (0.02) | 0.06 | 0.16 | 0.06 | (0.09) | (0.20) |
| Earnings Per Share (Diluted) | 0.21 | (0.32) | (0.02) | 0.06 | 0.16 | 0.06 | (0.09) | (0.20) |
| Weighted Average Shares Outstanding (Basic) | 9,046 | 9,026 | 9,046 | 9,031 | 8,981 | 8,167 | 8,164 | 7,810 |
| Weighted Average Shares Outstanding (Diluted) | 9,046 | 9,026 | 9,046 | 9,031 | 8,981 | 8,167 | 8,164 | 7,810 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ICCC
ImmuCell Corporation (NASDAQ: ICCC) is a stock listed on the Nasdaq Stock Market under the ticker symbol ICCC. It last traded at $11.25 (Nov 18, 2026, 4:00 PM ET), down 0.7% on the day. That gives ImmuCell a market capitalisation of $103.9M and a price-to-earnings ratio of 131.9.
Over the past 52 weeks ICCC has traded between $4.52 and $12.10.
Revenue for the quarter ended Mar 31, 2026 was $10.4M; net income $1.9M. Revenue was up 28.4% from $8.1M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $10.4M | $1.9M | 18.8% |
| Dec 31, 2025 | $7.6M | -$2.8M | -37.4% |
| Sep 30, 2025 | $5.5M | -$140.0K | -2.5% |
| Jun 30, 2025 | $6.4M | $502.0K | 7.8% |
From ImmuCell’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…